Across TCGA pan-cancer cohorts, RN7SKP193 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SKP193’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SKP193 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP193 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

STAD, LUAD, and LUSC are the cancer types where RN7SKP193 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP193 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	II,III,IV	+0.155	.010	2	view →
LUAD	All	All	+0.157	.037	1	view →
LUSC	Female	All	−0.073	.041	1	view →
THCA	All	All	−0.040	.044	1	view →
KIRC	Male	All	+0.029	.028	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RN7SKP193 RNA expression & survival · all RN7SKP193 data types